Skip to content
Search Classifications
Search for IPC and CPC classification codes or keywords
IPC Subgroup
A61K 47/62

the modifying agent being a protein, peptide or polyamino acid

Introduced: January 2017

Full Title

Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient > the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates > the non-active ingredient being a modifying agent > the modifying agent being a protein, peptide or polyamino acid

Classification Context

Section:
HUMAN NECESSITIES
Class:
MEDICAL OR VETERINARY SCIENCE; HYGIENE
Subclass:
PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES

3 direct subcodes

Child Classifications

Navigate with arrow keys, Enter to open

  • A61K 47/64 Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
  • A61K 47/65 Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
  • A61K 47/66 the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells

Top Applicants

Top 10 applicants by patent filingsfor class A61, 2013–2023, worldwide · Source: EPO PATSTAT

  1. PHILIPS ELECTRONICS NL 18,523
  2. NOVARTIS CH 14,253
  3. COVIDIEN US 13,953
  4. ROCHE CH 12,005
  5. CHINESE ACADEMY OF SCIENCES 11,955
  6. UNIVERSITY OF CALIFORNIA US 11,692
  7. HARVARD UNIVERSITY US 11,596
  8. L'OREAL FR 11,593
  9. P&G (PROCTER & GAMBLE COMPANY) US 11,297
  10. OLYMPUS CORPORATION JP 9,594